Deep Track Capital, LP 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-04-05 4:00 pm Purchase | 2024-03-27 | 13G | Avalo Therapeutics, Inc. AVTX | Deep Track Capital, LP | 114,775 9.990% | 114,775 (New Position) | Filing |